0.0031
+0.0004
+(14.81%)
At close: 1:35:27 PM EST
Breakdown
TTM
12/31/2023
12/31/2022
12/31/2021
12/31/2020
Operating Cash Flow
-758.9950
-1,030.5000
-2,044.3260
-2,486.7650
-3,215.6990
Investing Cash Flow
-2.8390
--
-8.7100
-50.4950
9.9800
Financing Cash Flow
670.3800
1,139.6750
1,647.3550
2,533.0420
3,151.2700
End Cash Position
6.0440
156.4570
47.2820
452.9630
457.1810
Interest Paid Supplemental Data
--
--
177.5000
--
--
Capital Expenditure
--
--
-8.7100
-50.4950
-97.3240
Issuance of Capital Stock
370.3800
491.4560
1,742.2610
1,635.5380
3,309.1300
Issuance of Debt
300.0000
675.0000
1,325.0000
1,010.0000
--
Repayment of Debt
--
--
-1,333.2000
-120.0000
--
Free Cash Flow
-761.8340
-1,030.5000
-2,053.0360
-2,537.2600
-3,313.0230
12/31/2020 - 9/2/2014
Upgrade to begin using 40 years of financial statements and get so much more.
Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.
UpgradeRelated Tickers
ENDV Endonovo Therapeutics, Inc.
0.0003
0.00%
RSPI RespireRx Pharmaceuticals Inc.
0.0011
+37.50%
TSOI Therapeutic Solutions International, Inc.
0.0002
0.00%
TXTM ProText Mobility, Inc.
0.0009
+12.50%
PHGUF Pharming Group N.V.
0.9360
0.00%
OCY.SG Oncimmune Holdings plc
0.1330
-3.62%
MRZM Marizyme, Inc.
0.0500
0.00%
LIXTW Lixte Biotechnology Holdings, Inc.
0.0213
+0.95%
PXMD PaxMedica, Inc.
0.0310
0.00%
LOBEF Lobe Sciences Ltd.
0.0150
-11.76%